Pelthos Therapeutics Inc. (PTHS) Ownership
PTHS ownership summary
as of October 18, 2026- Institutions
- 42.3% of shares outstanding
- Insiders
- 50.05% of shares outstanding
- Shares outstanding
- 3.8M
- Float
- 1.4M shares available to trade
- Short interest
- 5.06% 105K shares short
- Days to cover
- 2.89 short interest up 0.2% vs prior month
- Institutions 42.26%
- Insiders 50.05%
- Other investors 7.69%
PTHS insider transactions
latest 3| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-02 | Ezra M Friedberg | Sell | $20.92 | 558 | $11,673 |
| 2026-04-02 | Peter Greenleaf | Sell | $20.92 | 797 | $16,673 |
| 2026-04-02 | Richard Malamut | Sell | $20.92 | 590 | $12,343 |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
PTHS shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns PTHS
Institutional investors own 42.3% of Pelthos Therapeutics's shares and insiders 50.05%. Short interest is 5.06% of the float, or 2.89 days of average trading volume. The share count rose 215.5% since 2022.
Related: PTHS analyst forecast, PTHS key metrics. See the PTHS stock overview for the latest quote and news.
PTHS ownership FAQ
What percentage of Pelthos Therapeutics is owned by institutions?
Institutions hold 42.3% of Pelthos Therapeutics's shares outstanding; insiders hold 50.05%.
What is Pelthos Therapeutics's short interest?
105K shares of Pelthos Therapeutics were sold short, 5.06% of the float; at the average daily volume it would take 2.89 days to cover.
Are insiders buying or selling Pelthos Therapeutics?
Of the latest 3 reported insider transactions in Pelthos Therapeutics (since April 2, 2026), 0 were purchases and 3 were sales.
How many shares of Pelthos Therapeutics are outstanding?
Pelthos Therapeutics has 3.8M shares outstanding, of which 1.4M are in the public float.